The global pharmaceutical filtration market is projected to reach USD
22.71 billion by 2021 from USD 13.73 billion in 2016, at a CAGR of 10.6%
from 2016 to 2021.

Market growth is primarily driven by factors such as growing production
of generics, biologics, and large molecules; a need for clean and
bio-safe production facilities; and advancements in nanofiber
technology. Other factors supporting market growth include an increase
in R&D spending by pharmaceutical and biopharmaceutical companies and
regulatory mandate for cGMP. The emerging markets are also expected to
offer plenty of growth opportunities for players in the market.

In recent years, the Asian market for pharmaceutical filtration has
witnessed a significant growth. Strategic expansions by key market
players in emerging Asian countries and the growing contract research
and manufacturing services industry in India, South Korea, Singapore,
and China are some of the key factors fueling the growth in the Asian
market.